Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:39 pm Sale |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
Russell Investments Group Ltd. | 0 0.000% |
-2,250,881 (Position Closed) |
Filing History |
| 2022-02-11 4:21 pm Sale |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
ORBIMED ADVISORS LLC | 3,416,871 4.460% |
-82,375 (-2.35%) |
Filing History |
| 2022-02-10 12:24 pm Sale |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
PRIMECAP MANAGEMENT CO | 5,093,403 6.660% |
-340,440 (-6.27%) |
Filing History |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 3,867,671 5.060% |
391,361 (+11.26%) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
6,251,230 8.200% |
673,271 (+12.07%) |
Filing History |
| 2021-11-18 5:28 pm Sale |
2021-11-18 | 13D | Standard BioTools Inc. LAB |
Neuberger Berman Group LLC | 4,336,103 5.670% |
-308,451 (-6.64%) |
Filing History |
| 2021-05-10 5:20 pm Purchase |
2021-04-30 | 13D | Standard BioTools Inc. LAB |
Caligan Partners LP | 8,380,265 11.200% |
8,380,265 (New Position) |
Filing History |
| 2021-02-16 3:33 pm Purchase |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,536,350 9.900% |
257,826 (+3.54%) |
Filing History |
| 2021-02-16 12:35 pm Sale |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
EASTERLY INVESTMENT PARTNERS LLC | 0 0.000% |
-5,128,573 (Position Closed) |
Filing History |
| 2021-02-12 4:46 pm Purchase |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
ORBIMED ADVISORS LLC | 3,499,246 4.720% |
3,499,246 (New Position) |
Filing History |
| 2021-02-12 12:02 pm Sale |
2009-02-28 | 13G | Standard BioTools Inc. LAB |
PRIMECAP MANAGEMENT CO | 5,433,843 7.330% |
-1,044,000 (-16.12%) |
Filing History |
| 2021-02-11 6:34 pm Sale |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
Neuberger Berman Group LLC | 4,644,554 6.270% |
-1,024,787 (-18.08%) |
Filing History |
| 2021-02-10 10:52 am Sale |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 3,476,310 4.690% |
-933,466 (-21.17%) |
Filing History |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
BLACKROCK INC BLK |
5,577,959 7.500% |
287,638 (+5.44%) |
Filing History |